These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 36542475

  • 1. Efficacy and safety of interleukin-1 blockers in kidney transplant recipients with familial Mediterranean fever: a propensity score-matched cohort study.
    Mirioglu S, Dirim AB, Bektas M, Demir E, Tor YB, Ozluk Y, Kilicaslan I, Oto OA, Yalcinkaya Y, Caliskan Y, Artim-Esen B, Yazici H, Inanc M, Turkmen A, Gul A, Sever MS.
    Nephrol Dial Transplant; 2023 May 04; 38(5):1327-1336. PubMed ID: 36542475
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö, Kucuk H, Babaoglu H, Guven SC, Ozturk MA, Haznedaroglu S, Goker B, Tufan A.
    Mod Rheumatol; 2019 Mar 04; 29(2):363-366. PubMed ID: 29578360
    [Abstract] [Full Text] [Related]

  • 3. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X, Tian F, Wu B, Xu T.
    Cochrane Database Syst Rev; 2022 Mar 29; 3(3):CD010893. PubMed ID: 35349164
    [Abstract] [Full Text] [Related]

  • 4. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A, Derin ME, Albayrak F, Karakaş B, Karagöz Y.
    Adv Rheumatol; 2020 Jan 30; 60(1):12. PubMed ID: 32000860
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
    Kucuksahin O, Yildizgoren MT, Ilgen U, Ates A, Kinikli G, Turgay M, Erten S.
    Mod Rheumatol; 2017 Mar 30; 27(2):350-355. PubMed ID: 27328763
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y, Gezer HH, Duruöz MT.
    Rheumatol Int; 2022 Jan 30; 42(1):81-86. PubMed ID: 34550430
    [Abstract] [Full Text] [Related]

  • 11. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.
    Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y.
    J Nephrol; 2018 Jun 30; 31(3):453-455. PubMed ID: 29446001
    [Abstract] [Full Text] [Related]

  • 12. Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab.
    Druyan A, Giat E, Livneh A, Grossman C, Ben-Zvi I, Lidar M.
    Clin Exp Rheumatol; 2021 Jun 30; 39 Suppl 132(5):75-79. PubMed ID: 34369359
    [Abstract] [Full Text] [Related]

  • 13. The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease.
    Giat E, Ben-Zvi I, Lidar M, Livneh A.
    Int J Mol Sci; 2022 Apr 02; 23(7):. PubMed ID: 35409316
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
    Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H.
    Rheumatology (Oxford); 2020 Dec 01; 59(12):3892-3899. PubMed ID: 32556219
    [Abstract] [Full Text] [Related]

  • 15. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB, Özdel S, Yılmaz S, Kurt-Şükür ED, Ekim M, Yalçınkaya F.
    Clin Rheumatol; 2016 Feb 01; 35(2):441-6. PubMed ID: 25213327
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK, Beşbaş N, Topaloglu R, Ozen S.
    Rheumatol Int; 2015 Oct 01; 35(10):1733-7. PubMed ID: 26001859
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G, Kose R, Senturk T.
    Sao Paulo Med J; 2019 May 08; 137(1):39-44. PubMed ID: 31116269
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.
    Alpay N, Sumnu A, Calışkan Y, Yazıcı H, Türkmen A, Gül A.
    Rheumatol Int; 2012 Oct 08; 32(10):3277-9. PubMed ID: 20386914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.